Selecting an R&D Data Management Platform to Support the Development of Novel Antibody-Based Therapeutics
We assisted a Munich-based biotech specializing in monoclonal antibody-based therapeutics in transitioning from paper-based processes to an advanced R&D data management platform. Through our Digital Blueprint methodology, we identified the company's reliance on inefficient Excel processes and provided a strategic plan to enhance data flow, integrity, and reuse across the organization. This initiative significantly improved research efficiency and set the foundation for their digital transformation journey.
Related Resources
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...